| 1 | Identifying Subgroup at High Risk of Transarterial Chemoembolization Failure Among Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation | 2.5 | 0 | Citations (PDF) |
| 2 | 13-3: GRAFT PANCREATITIS FOLLOWING SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: PRESENTATION, RISK FACTORS AND OUTCOMES | 2.1 | 0 | Citations (PDF) |
| 3 | 16-3: FROM VISION TO PRECISION: REAL-TIME HYPERSPECTRAL ASSESSMENT OF PANCREATIC GRAFT PERFUSION AND IMPLICATION TO VENOUS GRAFT THROMBOSIS | 2.1 | 0 | Citations (PDF) |
| 4 | Liver Transplantation from Elderly Donors (≥85 Years Old) | 3.8 | 3 | Citations (PDF) |
| 5 | Closed-loop insulin delivery systems in patients with pancreatitis or pancreatectomy-induced diabetes: A case series | 3.5 | 6 | Citations (PDF) |
| 6 | Repeat laparoscopic liver resection after an initial open hepatectomy | 0.3 | 4 | Citations (PDF) |
| 7 | New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma | 4.6 | 14 | Citations (PDF) |
| 8 | Influence of pancreatic fistula on survival after upfront pancreatoduodenectomy for pancreatic ductal adenocarcinoma: multicentre retrospective study | 2.9 | 3 | Citations (PDF) |
| 9 | Predictive nomograms for postoperative 90-day morbidity and mortality in patients undergoing liver resection for various hepatobiliary diseases | 1.8 | 2 | Citations (PDF) |
| 10 | Prognostic impact of surgical margins for hepatocellular carcinoma according to preoperative alpha-fetoprotein level | 0.3 | 8 | Citations (PDF) |
| 11 | Liver stiffness-based model predicts hepatic venous pressure gradient in patients with liver disease | 0.3 | 7 | Citations (PDF) |
| 12 | Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin‐based chemotherapy for primary colorectal cancer | 1.5 | 2 | Citations (PDF) |
| 13 | Subjective Difficulty Scale in Liver Transplantation: A Prospective Observational Study | 2.0 | 6 | Citations (PDF) |
| 14 | Early‐ and long‐term outcomes of liver transplantation with rescue allocation grafts | 1.7 | 1 | Citations (PDF) |
| 15 | Effectiveness of first‐line cetuximab in wild‐type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort | 2.5 | 9 | Citations (PDF) |
| 16 | Predicting the risk of post-hepatectomy portal hypertension using a digital twin: A clinical proof of concept | 4.2 | 85 | Citations (PDF) |
| 17 | Middle and left hepatic vein trunk control during laparoscopic liver resection (with video) | 2.3 | 5 | Citations (PDF) |
| 18 | Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha‐fetoprotein score: a new prognostic risk factor | 2.0 | 16 | Citations (PDF) |
| 19 | Initial piggyback technique facilitates late liver retransplantation – a retrospective monocentric study | 2.0 | 4 | Citations (PDF) |
| 20 | Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort | 5.5 | 25 | Citations (PDF) |
| 21 | Mild increases in plasma creatinine after intermediate to high-risk abdominal surgery are associated with long-term renal injury | 2.2 | 7 | Citations (PDF) |
| 22 | Early Versus Late Hepatocellular Carcinoma Recurrence After Transplantation: Predictive Factors, Patterns, and Long-term Outcome | 2.1 | 31 | Citations (PDF) |
| 23 | The prognostic significance of serum aspartate transaminase and gamma‐glutamyl transferase in liver deceased donors | 2.0 | 6 | Citations (PDF) |
| 24 | Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group | 1.8 | 5 | Citations (PDF) |
| 25 | Study Protocol of the PreFiPS Study: Prevention of Postoperative Pancreatic Fistula by Somatostatin Compared With Octreotide, a Prospective Randomized Controlled Trial | 2.4 | 4 | Citations (PDF) |
| 26 | Maca against Echinococcosis?—A Reverse Approach from Patient to In Vitro Testing | 2.9 | 8 | Citations (PDF) |
| 27 | Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: An intent-to-treat analysis | 1.8 | 26 | Citations (PDF) |
| 28 | Liver Resection for Early Hepatocellular Carcinoma | 4.6 | 29 | Citations (PDF) |
| 29 | Does Fungal Biliary Contamination after Preoperative Biliary Drainage Increase Postoperative Complications after Pancreaticoduodenectomy? | 3.8 | 10 | Citations (PDF) |
| 30 | Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment | 14.3 | 126 | Citations (PDF) |
| 31 | Laparoscopic Radical Antegrade Modular Pancreatosplenectomy (RAMPS) Technique: Toward the Standardization of the Technique (With Video) | 0.9 | 1 | Citations (PDF) |
| 32 | Predictors of unresectability after portal vein embolization for centrally located cholangiocarcinoma | 1.8 | 11 | Citations (PDF) |
| 33 | Indocyanine Green Fluorescence Imaging to Predict Graft Survival After Orthotopic Liver Transplantation: A Pilot Study | 2.5 | 14 | Citations (PDF) |
| 34 | What is the Prognostic Value of a Discordant Radiologic and Pathologic Response in Patients Undergoing Resection of Colorectal Liver Metastases After Preoperative Chemotherapy? | 2.3 | 25 | Citations (PDF) |
| 35 | Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of Cirrhosis | 2.5 | 120 | Citations (PDF) |
| 36 | Spleen volumetry and liver transient elastography: Predictors of persistent posthepatectomy decompensation in patients with hepatocellular carcinoma | 1.8 | 10 | Citations (PDF) |
| 37 | A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey | 2.3 | 5 | Citations (PDF) |
| 38 | Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study | 1.8 | 66 | Citations (PDF) |
| 39 | Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma | 2.3 | 62 | Citations (PDF) |
| 40 | Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarcinoma: An AGEO multicentric retrospective cohort | 1.8 | 15 | Citations (PDF) |
| 41 | Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation | 1.8 | 28 | Citations (PDF) |
| 42 | “Laparoscopic Para-Aortic Lymph Node Sampling” First Approach for Pancreatic Adenocarcinoma as an Oncological Practice | 1.6 | 6 | Citations (PDF) |
| 43 | Late hepaticartery thrombosis after liver transplantation: which strategy? A single‐center retrospective study | 2.0 | 5 | Citations (PDF) |
| 44 | Indocyanine green fluorescence imaging to evaluate graft perfusion during liver transplantation | 0.3 | 28 | Citations (PDF) |
| 45 | Evaluation of a micro-spectrometer for the real-time assessment of liver graft with mild-to-moderate macrosteatosis: A proof of concept study | 4.2 | 23 | Citations (PDF) |
| 46 | Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome | 4.6 | 37 | Citations (PDF) |
| 47 | Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating Complication | 1.7 | 9 | Citations (PDF) |
| 48 | Long-term survival and cure model following liver resection for breast cancer metastases | 2.3 | 21 | Citations (PDF) |
| 49 | Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort | 2.6 | 18 | Citations (PDF) |
| 50 | Natural history of portal vein embolization before liver resection: a 23-year analysis of intention-to-treat results | 1.8 | 67 | Citations (PDF) |
| 51 | Suitability of livers for transplantation when treated by normothermic machine perfusion | 1.7 | 11 | Citations (PDF) |
| 52 | Impact of laparoscopy in patients aged over 70 years requiring distal pancreatectomy: a French multicentric comparative study | 2.3 | 16 | Citations (PDF) |
| 53 | How to Reliably Assess Nodal Status in Distal Pancreatectomy for Adenocarcinoma | 0.9 | 7 | Citations (PDF) |
| 54 | Totally intra-corporeal Pringle maneuver during laparoscopic liver resection | 0.3 | 14 | Citations (PDF) |
| 55 | International Summit on Laparoscopic Pancreatic Resection (ISLPR) “Coimbatore Summit Statements” | 2.1 | 20 | Citations (PDF) |
| 56 | Left-liver Adult-to-Adult Living Donor Liver Transplantation | 4.6 | 21 | Citations (PDF) |
| 57 | Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) | 2.5 | 148 | Citations (PDF) |
| 58 | Postoperative Infectious Complications Impact Long-Term Survival in Patients Who Underwent Hepatectomies for Colorectal Liver Metastases: a Propensity Score Matching Analysis | 1.7 | 19 | Citations (PDF) |
| 59 | How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort | 2.3 | 80 | Citations (PDF) |
| 60 | Prediction of the Total Liver Weight using anthropological clinical parameters: does complexity result in better accuracy? | 0.3 | 10 | Citations (PDF) |
| 61 | Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection? | 2.5 | 107 | Citations (PDF) |
| 62 | Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease | 1.5 | 22 | Citations (PDF) |
| 63 | A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation | 2.5 | 158 | Citations (PDF) |
| 64 | Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma | 1.8 | 61 | Citations (PDF) |
| 65 | Extreme large‐for‐size syndrome after adult liver transplantation: A model for predicting a potentially lethal complication | 2.5 | 33 | Citations (PDF) |
| 66 | Postoperative biological and clinical outcomes following uncomplicated pancreaticoduodenectomy | 0.6 | 2 | Citations (PDF) |
| 67 | Intention‐to‐treat analysis of percutaneous endovascular treatment of hepatic artery stenosis after orthotopic liver transplantation | 2.5 | 43 | Citations (PDF) |
| 68 | Repeat liver retransplantation: rationale and outcomes | 1.7 | 19 | Citations (PDF) |
| 69 | Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors? | 3.4 | 117 | Citations (PDF) |
| 70 | Laparoscopic left pancreatectomy: early results after 115 consecutive patients | 2.3 | 20 | Citations (PDF) |
| 71 | Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis | 0.3 | 58 | Citations (PDF) |
| 72 | Outcomes of Rehepatectomy for Colorectal Liver Metastases: A Contemporary Multi-Institutional Analysis from the French Surgical Association Database | 2.3 | 15 | Citations (PDF) |
| 73 | Congenital bile duct cyst (BDC) is a more indolent disease in children compared to adults, except for Todani type IV-A BDC: results of the European multicenter study of the French Surgical Association | 0.3 | 16 | Citations (PDF) |
| 74 | Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma | 4.6 | 116 | Citations (PDF) |
| 75 | Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases | 2.3 | 34 | Citations (PDF) |
| 76 | CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma | 3.6 | 143 | Citations (PDF) |
| 77 | Early and Long-term Oncological Outcomes After Laparoscopic Resection for Colorectal Liver Metastases | 4.6 | 98 | Citations (PDF) |
| 78 | Arterial Lactate Concentration at the End of an Elective Hepatectomy Is an Early Predictor of the Postoperative Course and a Potential Surrogate of Intraoperative Events | 4.6 | 57 | Citations (PDF) |
| 79 | Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation | 10.1 | 49 | Citations (PDF) |
| 80 | Failure to Achieve a 2-Stage Hepatectomy for Colorectal Liver Metastases | 4.6 | 60 | Citations (PDF) |
| 81 | Spontaneous Splenorenal Shunt in Liver Transplantation | 2.1 | 38 | Citations (PDF) |
| 82 | Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation? | 4.2 | 127 | Citations (PDF) |
| 83 | Les traitements néo-adjuvants peuvent permettre à des tumeurs non resécables de le devenir | 0.6 | 2 | Citations (PDF) |
| 84 | Stump closure reinforcement with absorbable fibrin collagen sealant sponge (TachoSil) does not prevent pancreatic fistula after distal pancreatectomy: the FIABLE multicenter controlled randomized study | 1.7 | 71 | Citations (PDF) |
| 85 | Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort | 2.3 | 75 | Citations (PDF) |
| 86 | Laparoscopic Pancreaticoduodenectomy: Right Posterior Superior Mesenteric Artery “First” Approach | 2.3 | 20 | Citations (PDF) |
| 87 | Laparoscopic Pancreaticoduodenectomy: Hybrid Surgical Technique | 0.7 | 15 | Citations (PDF) |
| 88 | Two-Stage Hepatectomy Versus 1-Stage Resection Combined With Radiofrequency for Bilobar Colorectal Metastases | 4.6 | 74 | Citations (PDF) |
| 89 | Laparoscopic resection of hepatocellular carcinoma: a French survey in 351 patients | 0.3 | 109 | Citations (PDF) |
| 90 | Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association | 0.3 | 151 | Citations (PDF) |
| 91 | The Postresection Alpha-Fetoprotein in Cirrhotic Patients with Hepatocellular Carcinoma. An Independent Predictor of Outcome | 1.7 | 11 | Citations (PDF) |
| 92 | Actual incidence and long-term consequences of posthepatectomy liver failure after hepatectomy for colorectal liver metastases | 1.8 | 50 | Citations (PDF) |
| 93 | A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases | 5.5 | 18 | Citations (PDF) |
| 94 | Comparison of Complete Pathologic Response and Hepatic Injuries Between Hepatic Arterial Infusion and Systemic Administration of Oxaliplatin in Patients with Colorectal Liver Metastases | 2.3 | 39 | Citations (PDF) |
| 95 | Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head | 0.3 | 27 | Citations (PDF) |
| 96 | Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma | 1.7 | 17 | Citations (PDF) |
| 97 | Portal stenting for hepatocellular carcinoma extending into the portal vein in cirrhotic patients | 1.5 | 12 | Citations (PDF) |
| 98 | Posthepatectomy Portal Vein Pressure Predicts Liver Failure and Mortality after Major Liver Resection on Noncirrhotic Liver | 4.6 | 129 | Citations (PDF) |
| 99 | Role of Laparoscopic Distal Pancreatectomy for Solid Pseudopapillary Tumor | 1.5 | 7 | Citations (PDF) |
| 100 | New Paradigms in Post-hepatectomy Liver Failure | 1.7 | 88 | Citations (PDF) |
| 101 | External Pancreatic Duct Stent Decreases Pancreatic Fistula Rate After Pancreaticoduodenectomy | 4.6 | 257 | Citations (PDF) |
| 102 | Image of the Month—Quiz Case | 2.4 | 1 | Citations (PDF) |
| 103 | Laparoscopic Roux-en-Y gastric bypass: comparison between hand-sewn and mechanical gastrojejunostomy | 1.7 | 20 | Citations (PDF) |
| 104 | Prise en charge thérapeutique du carcinome hépatocellulaire. Où en sommes-nous ? Où allons-nous ? | 0.6 | 7 | Citations (PDF) |
| 105 | Hepatocellular adenoma management and phenotypic classification | 10.1 | 408 | Citations (PDF) |
| 106 | Hepatocellular adenomas | 3.9 | 16 | Citations (PDF) |
| 107 | Internal Radiotherapy of Liver Cancer with Rat Hepatocarcinoma-Intestine-Pancreas Gene as a Liver Tumor-Specific Promoter | 3.2 | 29 | Citations (PDF) |
| 108 | A Single-Institution Prospective Study of Laparoscopic Pancreatic Resection | 2.4 | 73 | Citations (PDF) |
| 109 | Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management | 16.8 | 30 | Citations (PDF) |
| 110 | A Second Liver Resection Due to Recurrent Colorectal Liver Metastases | 2.4 | 65 | Citations (PDF) |
| 111 | Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry | 10.1 | 584 | Citations (PDF) |
| 112 | Laparoscopic central pancreatectomy: Single institution experience of 6 patients | 1.8 | 86 | Citations (PDF) |
| 113 | Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapy | 0.9 | 23 | Citations (PDF) |
| 114 | Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomas | 6.5 | 246 | Citations (PDF) |
| 115 | Laparoscopic versus open approach for solitary insulinoma | 2.3 | 80 | Citations (PDF) |
| 116 | Surgical Resection after Radiochemotherapy in Patients with Unresectable Adenocarcinoma of the Pancreas | 0.7 | 93 | Citations (PDF) |
| 117 | Prognostic Factors and Longterm Survival after Hepatic Resection for Hepatocellular Carcinoma Originating from Noncirrhotic Liver | 0.7 | 110 | Citations (PDF) |
| 118 | Prise en charge des cancers colorectaux des sujets âgés | 0.9 | 12 | Citations (PDF) |
| 119 | Title is missing! | 1.4 | 3 | Citations (PDF) |
| 120 | Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver | 0.9 | 214 | Citations (PDF) |
| 121 | Obesity as a Risk Factor for Hepatocellular Carcinoma in a Noncirrhotic Patient | 3.1 | 24 | Citations (PDF) |
| 122 | Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis1 | 0.7 | 85 | Citations (PDF) |
| 123 | Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas | 4.2 | 133 | Citations (PDF) |
| 124 | Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment | 4.2 | 19 | Citations (PDF) |
| 125 | Duct to duct biliary reconstruction during major hepatectomy with limited resection of the biliary confluence | 1.7 | 0 | Citations (PDF) |